Shilepi 10mg Injection
Marketer
Shilpa Medicare Ltd
Salt Composition
Epirubicin (10mg)
Overview Shilepi 10mg Injection
Shilepi 10mg injection treats various hematologic malignancies and cancers affecting the breast, stomach, lungs, ovaries, and soft tissues. It also aids in preventing bladder cancer relapse post-surgery. Administered intravenously by a healthcare professional, it's used alone or in conjunction with other drugs within a chemotherapy regimen. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Adhere strictly to the prescribed dosage; misuse can result in severe adverse reactions. Therapeutic effects might not be immediately apparent, requiring weeks or months; discontinue only under medical guidance. Shilepi reduces contraceptive efficacy; reliable birth control is advised for both partners throughout treatment. Common side effects comprise nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and skin rashes. The drug's impact on blood cell counts increases infection risk, potentially life-threatening. Regular blood tests are mandatory to monitor hematologic parameters, as well as renal, hepatic, and cardiac function. Prior to treatment, disclose any liver or heart conditions, and provide a complete medication list to your physician, as drug interactions can significantly influence Shilepi's efficacy and mechanism. Report any pregnancy or breastfeeding.
Uses of Shilepi 10mg Injection
Malignancy
Major Benefits of Shilepi 10mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Shilepi 10mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Shilepi 10mg Injection:
The medication will be administered by your healthcare provider. Self-medication is not permitted.
How Shilepi 10mg Injection works:
Shilepi 10mg Injection is a breast cancer treatment that inhibits topoisomerase II, an enzyme crucial for breast cancer cell DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, arresting cancer cell proliferation and ultimately inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Shilepi 10mg Injection is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Shilepi 10mg Injection during pregnancy carries a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Shilepi 10mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be compromised by Shilepi 10mg Injection side effects. Nausea and vomiting, potential side effects of Shilepi 10mg Injection, can temporarily impair driving skills.
KidneySAFE IF PRESCRIBED
Shilepi 10mg Injection appears safe for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary; however, medical advice is recommended. For patients exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages should be evaluated.
LiverCAUTION
Patients with liver impairment should use Shilepi 10mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised. Shilepi 10mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Shilepi 10mg Injection :
NA
Facts to Know About Shilepi 10mg Injection
| Label | Value |
|---|---|
| Chemical Category | Anthracycline Analog |
| Developing Habits | No. |
| Type of Therapy | Cancer Drugs |
| Actions | Cytotoxic alkaloids |
3,018 People bought this recently